Modulation of Aldehyde Dehydrogenase Activity Affects (±)-4-Hydroxy-2E-nonenal (HNE) Toxicity and HNE–Protein Adduct Levels in PC12 Cells

[1]  Houeto Jean-Luc.  [Parkinson's disease]. , 2022, La Revue du praticien.

[2]  K. Lee,et al.  Kaempferol Attenuates 4-Hydroxynonenal-Induced Apoptosis in PC12 Cells by Directly Inhibiting NADPH Oxidase , 2011, Journal of Pharmacology and Experimental Therapeutics.

[3]  M. Chopp,et al.  Cerebrolysin enhances neurogenesis in the ischemic brain and improves functional outcome after stroke , 2010, Journal of neuroscience research.

[4]  V. Vasiliou,et al.  The Aldehyde Dehydrogenase Gene Superfamily Resource Center , 2009, Human Genomics.

[5]  M. Zhang,et al.  Overexpression of aldehyde dehydrogenase 1A1 reduces oxidation‐induced toxicity in SH‐SY5Y neuroblastoma cells , 2009, Journal of neuroscience research.

[6]  Young Jin Jang,et al.  Piceatannol Attenuates 4‐Hydroxynonenal‐Induced Apoptosis of PC12 Cells by Blocking Activation of c‐Jun N‐Terminal Kinase , 2009, Annals of the New York Academy of Sciences.

[7]  Mun Kyung Hwang,et al.  Cocoa procyanidins attenuate 4-hydroxynonenal-induced apoptosis of PC12 cells by directly inhibiting mitogen-activated protein kinase kinase 4 activity. , 2009, Free radical biology & medicine.

[8]  E. Niki,et al.  Induction of adaptive response and enhancement of PC12 cell tolerance by lipopolysaccharide primarily through the upregulation of glutathione S-transferase A3 via Nrf2 activation. , 2008, Free radical biology & medicine.

[9]  Cornelius J Werner,et al.  Proteome analysis of human substantia nigra in Parkinson's disease , 2008, Proteome Science.

[10]  H. Raza,et al.  4-hydroxynonenal induces mitochondrial oxidative stress, apoptosis and expression of glutathione S-transferase A4-4 and cytochrome P450 2E1 in PC12 cells. , 2006, Toxicology and applied pharmacology.

[11]  S. Mandel,et al.  Gene Expression Profiling of Sporadic Parkinson's Disease Substantia Nigra Pars Compacta Reveals Impairment of Ubiquitin‐Proteasome Subunits, SKP1A, Aldehyde Dehydrogenase, and Chaperone HSC‐70 , 2005, Annals of the New York Academy of Sciences.

[12]  G. Poli,et al.  Signaling kinases modulated by 4-hydroxynonenal. , 2004, Free radical biology & medicine.

[13]  S. Lipton,et al.  Molecular pathways to neurodegeneration , 2004, Nature Medicine.

[14]  J. Costentin,et al.  Toxicity of a treatment associating dopamine and disulfiram for catecholaminergic neuroblastoma SH-SY5Y cells: relationships with 3,4-dihydroxyphenylacetaldehyde formation. , 2004, Neurotoxicology.

[15]  Dagmar Galter,et al.  ALDH1 mRNA: presence in human dopamine neurons and decreases in substantia nigra in Parkinson's disease and in the ventral tegmental area in schizophrenia , 2003, Neurobiology of Disease.

[16]  T. Grune,et al.  Intracellular metabolism of 4-hydroxynonenal. , 2003, Molecular aspects of medicine.

[17]  R. Schaur,et al.  Basic aspects of the biochemical reactivity of 4-hydroxynonenal. , 2003, Molecular aspects of medicine.

[18]  Graeme Eisenhofer,et al.  3,4-Dihydroxyphenylacetaldehyde potentiates the toxic effects of metabolic stress in PC12 cells , 2000, Brain Research.

[19]  G. Eisenhofer,et al.  Metabolic stress in PC12 cells induces the formation of the endogenous dopaminergic neurotoxin, 3,4‐dihydroxyphenylacetaldehyde , 2000, Journal of neuroscience research.

[20]  C. Bode,et al.  Induction of rat aortic smooth muscle cell growth by the lipid peroxidation product 4-hydroxy-2-nonenal. , 1998, Circulation.

[21]  J. Lipsky,et al.  Inhibition of recombinant human mitochondrial and cytosolic aldehyde dehydrogenases by two candidates for the active metabolites of disulfiram. , 1997, Biochemistry.

[22]  M. Mattson,et al.  The Lipid Peroxidation Product, 4‐Hydroxy‐2‐trans‐Nonenal, Alters the Conformation of Cortical Synaptosomal Membrane Proteins , 1997, Journal of neurochemistry.

[23]  Mark A. Smith,et al.  4‐Hydroxynonenal‐Derived Advanced Lipid Peroxidation End Products Are Increased in Alzheimer's Disease , 1997, Journal of neurochemistry.

[24]  N. Hattori,et al.  Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[25]  B. Yu,et al.  Alterations in mitochondrial membrane fluidity by lipid peroxidation products. , 1994, Free radical biology & medicine.

[26]  B. Dubois,et al.  Lesions of basal ganglia due to disulfiram neurotoxicity. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[27]  G. Ansari,et al.  Regulation of 4-hydroxynonenal mediated signaling by glutathione S-transferases. , 2005, Methods in enzymology.

[28]  Y. Awasthi,et al.  Lipid peroxidation and cell cycle signaling: 4-hydroxynonenal, a key molecule in stress mediated signaling. , 2003, Acta biochimica Polonica.